TikTok creator Wayde Cadogan opens up about her alopecia journey on social media, spreading awareness and building an ...

Comorbid chronic inflammatory diseases (CIDs) influence the prognosis of alopecia areata (AA), according to a research letter ...

Having asthma, Hashimoto’s thyroiditis or atopic dermatitis in addition to alopecia areata raised the odds for early-onset, severe and prolonged alopecia areata, according to a research letter ...

Another treatment is Litfulo, a pill from drug manufacturer Pfizer for people ages 12 and older with severe alopecia areata. Right now, Tisdale isn’t taking Litfulo or any other prescriptions to ...

For instance, two phase 3 trials of baricitinib, a selective JAK1 and JAK2 inhibitor, demonstrated significant hair regrowth in patients with severe alopecia areata. In these studies, a ...

The actress and singer was diagnosed with alopecia areata in her mid-20s For Ashley Tisdale, making changes to her haircare routine was all a part of being diagnosed with alopecia. The actress and ...

A recent case-control study found a significant association in the prevalence of alopecia areata in patients diagnosed with celiac disease.

Beyond cosmetic concerns, alopecia areata deeply affects mental health. A domestic survey found that 40% of patients ...

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...

Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system attacks on hair follicles. Breakdown of immune privilege in hair follicles leads to ...

Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...

Topical Gel pre-IND meeting and on track to begin Phase 2a clinical trial in alopecia areata in Q2 2025 Unaudited cash and cash equivalents of approximately $70 million as of December 31, 2024 WARREN, ...